Delineation of lung cancer with FDG PET/CT during radiation therapy

被引:0
作者
J. Ganem
S. Thureau
I. Gardin
R. Modzelewski
S. Hapdey
P. Vera
机构
[1] Henri Becquerel Cancer Centre and Rouen University Hospital,Nuclear Medicine Department
[2] University of Rouen,QuantIF
[3] Henri Becquerel Cancer Centre and Rouen University Hospital,LITIS (EA [Equipe d’Accueil] 4108
来源
Radiation Oncology | / 13卷
关键词
Delineation; Radiation therapy; PET/CT; Lung cancer; perPET-RT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 186 条
[1]  
Albain KS(2009)Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet Lond Engl 374 379-386
[2]  
Swann RS(2011)Non-small-cell lung cancer Lancet Lond Engl 378 1727-1740
[3]  
Rusch VW(2006)The role of PET/CT scanning in radiotherapy planning The British Journal of Radiology 79 S27-S35
[4]  
Turrisi AT(2015)FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 Eur J Nucl Med Mol Imaging 42 328-354
[5]  
Shepherd FA(2007)PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes Int J Radiat Oncol Biol Phys 68 771-778
[6]  
Smith C(2010)Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition Dis Esophagus Off J Int Soc Dis Esophagus ISDE 23 493-501
[7]  
Goldstraw P(2015)Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Lancet Oncol 16 187-199
[8]  
Ball D(2009)Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18) Fluorodeoxyglucose-PET-CT scan Radiother Oncol J Eur Soc Ther Radiol Oncol 91 386-392
[9]  
Jett JR(2015)Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer J Nucl Med Off Publ Soc Nucl Med 56 196-203
[10]  
Le Chevalier T(2012)Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC) Radiother Oncol J Eur Soc Ther Radiol Oncol 102 251-257